Okay, let's tackle this question about 'Hand Foot' syndrome. First, I need to recall what Hand-Foot Syndrome (HFS), also known as palmar-plantar erythrodysesthesia, is. It's a side effect of certain chemotherapy drugs. The question is asking which drugs can cause it.

The core concept here is the mechanism of HFS. It's related to the accumulation of certain chemotherapeutic agents in the skin of the palms and soles, leading to redness, swelling, and pain. The drugs involved are usually those that are metabolized by specific enzymes or have a high concentration in these areas.

Now, the correct answer is likely one of the options A-D, but since the options aren't listed here, I need to think about the common culprits. Drugs like capecitabine, 5-fluorouracil, and sorafenib are known to cause HFS. Capecitabine is a prodrug that gets converted to 5-FU in the body. The thymidine synthase enzyme plays a role in its metabolism, and maybe that's part of the mechanism here.

For the incorrect options, I need to consider other chemotherapeutic agents. For example, doxorubicin is more associated with cardiotoxicity, and cisplatin with nephrotoxicity. If the options included these, they would be incorrect. Also, drugs like vincristine cause peripheral neuropathy, not HFS.

The clinical pearl here is that HFS is a classic side effect of capecitabine and other targeted therapies like sorafenib. Students should remember that when a question mentions HFS, these drugs are the primary suspects. Mnemonically, think "CAP" for capecitabine and "SOR" for sorafenib.

**Core Concept:** Hand-Foot Syndrome (HFS) is a dermatologic toxicity caused by accumulation of chemotherapeutic agents in palmar-plantar sweat glands. It is most commonly associated with **capecitabine**, **sorafenib**, and **sunitinib**, which are metabolized via thymidine synthase or tyrosine kinase inhibition pathways. The pathophysiology involves local irritation and vascular injury in acral regions.

**Why the Correct Answer is Right:** Capecitabine, a prodrug of 5-fluorouracil, is converted to active metabolites in tissues with high thymidine phosphorylase activity (e.g., tumors and skin). Palmar-plantar tissues have high concentrations of this enzyme, leading to drug accumulation. Sorafenib and sunitinib, multikinase inhibitors, cause HFS via endothelial injury and impaired microcirculation. These agents directly damage small vessels in the hands/feet, triggering erythema, desquamation, and pain.

**Why Each Wrong Option is Incorrect:**
**Option A:** *Doxorubicin* primarily causes cardiotoxicity and myelosuppression, not HFS.
**Option B:** *Cisplatin* is notorious for nephrotoxicity and ototoxicity, not acral toxicity.
**Option C:** *Vincristine* induces dose-dependent peripheral neuropathy, not HFS.
**Option D:** *Paclitaxel* is associated with neuroto

✓ Correct Answer: B. Capecitabine